RecruitingOpen Angle Glaucoma (OAG)Ocular Hypertension (OH)
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Sponsor: Glaukos Corporation
You may qualify if…
- ✓ Diagnosis of Open-angle glaucoma
- ✓ 18 years of age or older
You may not qualify if…
- ✕ Subject who is breast-feeding or pregnant
Where it's recruiting
Wisconsin
Kenosha
Source: ClinicalTrials.gov · NCT07400926 · last updated 2026-02-27